Stabilized formulations containing antiinterleukin-6 receptor (IL-6R) antibodies

Details for Australian Patent Application No. 2011204311 (hide)

Owner Dix, D. Graham, K. Walsh, S. Kamen, D. Regeneron Pharmaceuticals, Inc.

Inventors Dix, Daniel B.; Graham, Kenneth S.; Kamen, Douglas E.; Walsh, Scott M.

Agent Watermark

Pub. Number AU-A-2011204311

PCT Pub. Number WO2011/085158

Priority 61/293,227 08.01.10 US; 12/986,223 07.01.11 US

Filing date 7 January 2011

Wipo publication date 14 July 2011

International Classifications

A61K 9/08 Medicinal preparations characterised by special physical form - Solutions

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/485 - Morphinan derivatives, e.g. morphine, codeine

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/085158 Priority application(s): WO2011/085158

25 October 2012 Assignment before Grant

  Dix, Daniel; Walsh, Scott; Graham, Kenneth; Kamen, Douglas; Regeneron Pharmaceuticals, Inc. The application has been assigned to Regeneron Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011204313-Materials and methods for isothermal nucleic acid amplification

2011204288-Method and apparatus for adding CSG identities to a white list in connected mode